ArticleRSC advances2020
Argovit™ silver nanoparticles to fight Huanglongbing disease in Mexican limes (
Article in RSC advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 43 citations in OpenAlex.
- Review
- Assessing the Effects of Surface-Stabilized Zero-Valent Iron Nanoparticles on Diverse Bacteria Species Using Complementary Statistical Models.Journal of functional biomaterials · 2025Article
- Silver Nanoparticles Help Plants Grow, Alleviate Stresses, and Fight Against Pathogens.Plants (Basel, Switzerland) · 2025Review
- Effects of silver nanoparticles on the physiology, stress, and mineral uptake of banana cultivarsFrontiers in plant science · 2025Article
- Article
- Inhibition of Fusarium oxysporum growth in banana by silver nanoparticles: In vitro and in vivo assays.PloS one · 2025Article
- Article
- Innovative strategies for characterizing and managing huanglongbing in citrus.World journal of microbiology & biotechnology · 2024Review
- Trunk Injection of Citrus Trees with a Polymeric Nanobactericide Reduces Huanglongbing Severity Caused by Candidatus Liberibacter asiaticus.The plant pathology journal · 2024Article
- Screening Method and Antibacterial Activity of 1,3,4-Oxadiazole Sulfone Compounds against Citrus Huanglongbing.International journal of molecular sciences · 2023Article
- Nanobiotechnology in crop stress management: an overview of novel applications.Discover nano · 2023Review
- A Comparative Study of Cancer Cells Susceptibility to Silver Nanoparticles Produced by Electron Beam.Pharmaceutics · 2023Article
- Phytomediated Silver Nanoparticles (AgNPs) Embellish Antioxidant Defense System, Ameliorating HLB-Diseased 'Kinnow' Mandarin Plants.Molecules (Basel, Switzerland) · 2023Article
- Huanglongbing Pandemic: Current Challenges and Emerging Management Strategies.Plants (Basel, Switzerland) · 2022Review
- Bell Shape Curves of Hemolysis Induced by Silver Nanoparticles: Review and Experimental Assay.Nanomaterials (Basel, Switzerland) · 2022Review
- The Infectious Bronchitis Coronavirus Pneumonia Model Presenting a Novel Insight for the SARS-CoV-2 Dissemination Route.Veterinary sciences · 2021Article
- AgNPs Argovit™ Modulates Cyclophosphamide-Induced Genotoxicity on Peripheral Blood Erythrocytes In Vivo.Nanomaterials (Basel, Switzerland) · 2021Article
- Hemolysis of Human Erythrocytes by Argovit™ AgNPs from Healthy and Diabetic Donors: An In Vitro Study.Materials (Basel, Switzerland) · 2021Article
- Antibacterial and Antifungal Studies of Biosynthesized Silver Nanoparticles against Plant Parasitic NematodeMolecules (Basel, Switzerland) · 2021Article
- Controlling Citrus Huanglongbing: Green Sustainable Development Route Is the Future.Frontiers in plant science · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 3 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nowadays, Huanglongbing (HLB) disease, commonly known as "yellow dragon disease", affects citrus crops worldwide and has a devastating effect in the agro-industrial sector. Significant efforts have been made to fight the illness, but still, there is no effective treatment to eradicate the disease. This work is the first approach to evaluate the capacity of silver nanoparticles (AgNPs) to directly eradicate the bacteria responsible for Huanglongbing disease,
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.